1. Clinical Guideline CG181: Lipid Modification - Cardiovascular Risk Assessment and the Modification of Blood Lipids for the Primary and Secondary Prevention of Cardiovascular Disease,2014
2. 2016 Canadian cardiovascular society guidelines for the management of dyslipidemia for the prevention of cardiovascular disease in the Adult;Anderson;Can. J. Cardiol.,2016
3. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: a report of the American college of Cardiology/American heart association task Force on clinical practice guidelines;Grundy;J. Am. Coll. Cardiol.,2018
4. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk;Mach;Eur. Heart J.,2019
5. Comparison of five major guidelines for statin use in primary prevention in a contemporary general population;Mortensen;Ann. Intern. Med.,2018